Patents by Inventor Mark M. Rasenick

Mark M. Rasenick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Treating Mood and Anxiety Disorders
    Publication number: 20080292627
    Abstract: The invention relates method of disrupting the interface between Gs? and tubulin. The disruption of this interaction is a mechanism for treatment of mood and anxiety disorders and this interaction may be used to screen for and design therapeutics for mood and anxiety disorders.
    Type: Application
    Filed: May 5, 2006
    Publication date: November 27, 2008
    Applicant: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventors: Mark M. Rasenick, Brian T. Layden
  • Methods for assaying for antidepressant therapy markers
    Patent number: 7445888
    Abstract: The present invention relates generally to methods for assaying for agents that modify the association of Gs? with components of the plasma membrane or cytoskeleton of cells. The present invention also relates generally to methods of assaying for agents having antidepressant activity via analysis of the association of Gs? with components of the plasma membrane or cytoskeleton of cells using a fluorescent analog of Gs? and fluorescence resonance energy transfer (FRET).
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: November 4, 2008
    Assignee: The Board of Trustees of The University of Illinois
    Inventors: Mark M. Rasenick, Robert J. Donati, Sadamu Toki
  • Marker for antidepressant therapy and methods related thereto
    Patent number: 7118858
    Abstract: The present invention relates generally to methods for determining the effectiveness of ongoing antidepressant therapy via analysis of the association of Gs? with components of the plasma membrane or cytoskeleton of cells from peripheral tissues of the depressed individual as well as to methods involved in screening for effective antidepressant agents via their ability to cause a difference in the association of Gs? with components of the plasma membrane or cytoskeleton of cells.
    Type: Grant
    Filed: February 8, 2005
    Date of Patent: October 10, 2006
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Mark M. Rasenick, Robert J. Donati, Sadamu Toki
  • Marker for antidepressant therapy and methods related thereto
    Patent number: 6875566
    Abstract: The present invention relates generally to methods for determining the effectiveness of ongoing antidepressant therapy via analysis of the association of Gs? with components of the plasma membrane or cytoskeleton of cells from peripheral tissues of the depressed individual as well as to methods involved in screening for effective antidepressant agents via their ability to cause a difference in the association of Gs? with components of the plasma membrane or cytoskeleton of cells.
    Type: Grant
    Filed: July 30, 2001
    Date of Patent: April 5, 2005
    Assignee: The Board of Trustees of the University of Illinois
    Inventors: Mark M. Rasenick, Robert J. Donati, Sadamu Toki
  • Marker for antidepressant therapy and methods related thereto
    Publication number: 20020039752
    Abstract: The present invention relates generally to methods for determining the effectiveness of ongoing antidepressant therapy via analysis of the association of Gs&agr; with components of the plasma membrane or cytoskeleton of cells from peripheral tissues of the depressed individual as well as to methods involved in screening for effective antidepressant agents via their ability to cause a difference in the association of Gs&agr; with components of the plasma membrane or cytoskeleton of cells.
    Type: Application
    Filed: July 30, 2001
    Publication date: April 4, 2002
    Inventors: Mark M. Rasenick, Robert J. Donati, Sadamu Toki
  • Methods for assaying for antidepressant therapy markers
    Patent number: RE43712
    Abstract: The present invention relates generally to methods for assaying for agents that modify the association of Gs? with components of the plasma membrane or cytoskeleton of cells. The present invention also relates generally to methods of assaying for agents having antidepressant activity via analysis of the association of Gs? with components of the plasma membrane or cytoskeleton of cells using a fluorescent analog of Gs? and fluorescence resonance energy transfer (FRET).
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: October 2, 2012
    Assignee: The Board of Trustees of the Uniersity of Illinois
    Inventors: Mark M. Rasenick, Robert J. Donati, Sadamu Toki